Skip to content

JSPRW

Jasper Therapeutics, Inc.

NASDAQ · Healthcare · Biotechnology · US

$0.00
−84.62%
Ask drillr

Next report

Analyst consensus

Next report date
Nov 5, 2026
EPS estimate
-$0.08
Revenue estimate
$12.0M

Latest reported

Last report date
Aug 14, 2026
EPS actual
-$0.10
EPS estimate
-$0.27
Revenue actual
—
Revenue estimate
—

Track record

Trailing twelve quarters

EPS beats (12Q)
3
EPS misses (12Q)
1
EPS in line (12Q)
0
Avg surprise (4Q)
+65.8%
Revenue beats (12Q)
—
Earnings call history

No earnings call summaries available

Reported history
Report dateEPS estimateEPS actualSurpriseRevenue actual
Aug 14, 2026-$0.27-$0.10Beat 62.66%—
May 14, 2026-$0.49-$0.04Beat 91.76%—
Mar 30, 2026-$0.82$0.33Beat 140.37%—
Aug 13, 2025-$1.33-$1.74Miss -31.40%—
Dec 30, 2023—-$15——
Sep 29, 2023—-$0.00——

Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 9, 2026